Cambridge Trust’s Synopsys SNPS Stock Holding History

Cambridge Trust’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	-$4K	–	876
2022 Q3	$4K	Hold	13	–	–	﹤0.01%	733
2022 Q2	$4K	Sell	13 -78	-86%	-$23.5K	﹤0.01%	768
2022 Q1	$30K	Hold	91	–	–	﹤0.01%	617
2021 Q4	$34K	Buy	+91	New	+$30.7K	﹤0.01%	593

Other funds holding SNPS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cambridge Trust's SNPS Position: Q4 2022 in Review

Cambridge Trust sold out of Synopsys (SNPS) in Q4 2022, closing a stake of 13 shares — an estimated $4K sold.

Cambridge Trust first reported a position in SNPS in Q4 2021 and held it in 4 quarters. The position peaked at $34K in Q4 2021. 921 funds tracked by Wall St. Rank hold SNPS as of Q4 2022.

Cambridge Trust reported no remaining Synopsys position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 13 Synopsys shares in Q4 2022, an estimated $4K.
Cambridge Trust first reported a position in Synopsys in Q4 2021 and held it in 4 quarters.
Cambridge Trust's Synopsys position peaked at $34K in Q4 2021.
921 funds tracked by Wall St. Rank held Synopsys as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.